During use an unexpected flaking of the inner surface coating (blood contact) that has the potential for risk of embolism.
Source facts
Action
On 1/26/2004, the firm issued letters via Federal Express to all its direct consignees, informing them of the affected product and providing instructions on the recall.
Initiated
2004-01-26
Root cause
Other
Terminated
2007-11-27
Distribution
Nationwide to 11(eleven) hospitals. The product was shipped within the United States in IL, MA, NC, MD, MO, FL, CA, AZ, PA, and NY. The product was distributed to one consignee in Australia.
Recall number
Z-0015-2007
Recall status
Terminated
CDRH record ID
48062
FDA classified
2006-10-04
Recall event number
36138
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.